Alvotech (ALVO) vs Aurinia Pharmaceuticals Inc. (AUPH)
A side-by-side comparison of Alvotech and Aurinia Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALVO
Alvotech
$6.14HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
AUPH
Aurinia Pharmaceuticals Inc.
$15.69HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ALVO vs AUPH
growth of $100 · dividends reinvested · last 4yALVO -45.4% (-14.0%/yr)AUPH +66.3% (+13.6%/yr)AUPH compounded faster over this window
ALVO AUPH
ALVO vs AUPH: by the numbers
- •ALVO is the larger company ($2.08B vs $2.02B market cap).
- •AUPH is profitable (100.84% net margin) while ALVO runs a net loss (-36.51%).
- •ALVO grew revenue faster over the past five years (69.03% vs 40.17% CAGR).
Metrics side by side
Valuation
| Metric | ALVO | AUPH |
|---|---|---|
| P/E ratio | N/A | 6.85 |
| Forward P/E | N/A | 16.62 |
| P/S ratio | 4.22 | 6.48 |
| P/B ratio | N/A | 3.28 |
| EV / EBITDA | 41.97 | 11.16 |
| FCF yield | N/A | 8.60% |
Profitability
| Metric | ALVO | AUPH |
|---|---|---|
| Gross margin | 60.45% | 90.36% |
| Operating margin | 9.62% | 37.06% |
| Net margin | -36.51% | 100.84% |
| ROE | N/A | 51.09% |
| ROIC | 3.61% | 21.77% |
Growth (annualized)
| Metric | ALVO | AUPH |
|---|---|---|
| Revenue CAGR (5Y) | 69.03% | 40.17% |
| Total return CAGR (5Y) | N/A | -5.88% |
Frequently asked
- Which has grown faster, ALVO or AUPH?
- Over the past five years, ALVO grew revenue faster — ALVO at a 69.03% CAGR versus AUPH at 40.17%.
- Is ALVO or AUPH more profitable?
- AUPH runs the higher net margin — ALVO at -36.51% versus AUPH at 100.84%.
Go deeper
Dig into the metrics
Aurinia Pharmaceuticals P/E ratioAlvotech ROEAurinia Pharmaceuticals ROEAlvotech operating marginAurinia Pharmaceuticals operating marginAlvotech revenue growthAurinia Pharmaceuticals revenue growthAlvotech free cash flowAurinia Pharmaceuticals free cash flow
Alvotech & Aurinia Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.